A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with ...
Merck & Co. is continuing to tinker with its antibody-drug conjugate (ADC) alliance with Kelun-Biotech, agreeing (PDF) to pay $37.5 million to take up its option on one candidate while returning the ...
PRAGUE and LONDON--(BUSINESS WIRE)--SOTIO Biotech, a clinical-stage biopharmaceutical company owned by PPF Group, today presented the first preclinical data on SOT109, a novel antibody-drug conjugate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback